Cargando…

Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy

Detalles Bibliográficos
Autores principales:	Skolnik, Aaron D., Wang, Sumei, Gopal, Pallavi P., Mohan, Suyash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807681/ https://www.ncbi.nlm.nih.gov/pubmed/29459848 http://dx.doi.org/10.3389/fneur.2018.00051

Ejemplares similares

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response
por: Huang, Raymond Y., et al.
Publicado: (2015)

Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response
por: New, Pamela Zyman, et al.
Publicado: (2017)

Commentary: Deficient approaches to human neuroimaging
por: Bayati, Armin
Publicado: (2017)

Statistical inferences under the Null hypothesis: common mistakes and pitfalls in neuroimaging studies
por: Hupé, Jean-Michel
Publicado: (2015)

New perspectives in glioblastoma antiangiogenic therapy
por: Popescu, Alisa Madalina, et al.
Publicado: (2015)

Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma
por: Wong, Kelvin K., et al.
Publicado: (2016)

Neurodevelopmental Precursors and Consequences of Substance Use during Adolescence: Promises and Pitfalls of Longitudinal Neuroimaging Strategies
por: Fishbein, Diana H., et al.
Publicado: (2016)

Multiparametric MRI assessment of response to convection-enhanced intratumoral delivery of MDNA55, an interleukin-4 receptor targeted immunotherapy, for recurrent glioblastoma
por: Mohan, Suyash, et al.
Publicado: (2021)

Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations
por: Nery de Albuquerque Rego, Gabriel, et al.
Publicado: (2020)

Commentary: The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
por: Papo, David
Publicado: (2016)

Advances in functional neuroimaging in dementias and potential pitfalls
por: Standley, Katherine, et al.
Publicado: (2012)

Commentary: Sleep Deprivation Promotes Habitual Control over Goal-Directed Control: Behavioral and Neuroimaging Evidence
por: Boddez, Yannick, et al.
Publicado: (2018)

Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature
por: Khattab, Mohamed H., et al.
Publicado: (2015)

Potential and pitfalls of (89)Zr-immuno-PET to assess target status: (89)Zr-trastuzumab as an example
por: Huisman, Marc C., et al.
Publicado: (2021)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
por: Lee, Dae Ho
Publicado: (2018)

Pitfalls in Neuroimaging of Headache: A Case Report and Review of the Literature
por: Vallamkondu, V., et al.
Publicado: (2013)

Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
por: McCord, Matthew, et al.
Publicado: (2017)

Microbial Immuno-Communication in Neurodegenerative Diseases
por: Main, Bevan S., et al.
Publicado: (2017)

Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography
por: Ruiz-López, Eduardo, et al.
Publicado: (2021)

Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
por: Chinot, Olivier L., et al.
Publicado: (2013)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019)

Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy
por: Stadlbauer, Andreas, et al.
Publicado: (2017)

Contemporary Updates on Clinical Trials of Antiangiogenic Agents in the Treatment of Glioblastoma Multiforme
por: Kochar, Arshneel Singh, et al.
Publicado: (2018)

Practical management of heterogeneous neuroimaging metadata by global neuroimaging data repositories
por: Neu, Scott C., et al.
Publicado: (2012)

Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
por: Niedbała, Marcin, et al.
Publicado: (2022)

Current markers and their value in the era of immuno-oncology
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2017)

Computational Modeling and Neuroimaging Techniques for Targeting during Deep Brain Stimulation
por: Sweet, Jennifer A., et al.
Publicado: (2016)

Cognition and Neuroimaging in Schizophrenia
por: Calhoun, Vince D., et al.
Publicado: (2012)

ELISA in the multiplex era: Potentials and pitfalls
por: Tighe, Patrick J., et al.
Publicado: (2015)

TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy?
por: Otten, Jasmin, et al.
Publicado: (2010)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

Antiangiogenic platinum through glycan targeting
por: Peterson, Erica J., et al.
Publicado: (2017)

Commentary: Immuno-chemo-radio-therapy before esophagectomy: Our next standard?
por: Ripley, R. Taylor
Publicado: (2022)

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018)

In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma
por: Senrung, Anna, et al.
Publicado: (2023)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy
por: Cocola, Cinzia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4n3rgnmkrk2q6fk03fbvqael5s